Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиКвартальный отчет 2023-Q1
добавлен 29.06.2023
Idera Pharmaceuticals Мультипликаторы 2011-2024 | IDRA
Мультипликаторы по годам Idera Pharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.1 | 0.0 | -1.7 | -0.9 | -1.2 | -4.4 | -4.5 | -4.6 | -9.7 | -9.9 | -1.0 | -1.3 |
P/S |
0.3 | - | - | 33.9 | 106.5 | 322.8 | 10.6 | 896.7 | 5128.5 | 3848.8 | 390.2 | 562.9 |
EPS |
-7.2 | 33.5 | -3.3 | -3.0 | -2.2 | -0.4 | -0.3 | -0.4 | -0.5 | -0.5 | -0.8 | -1.0 |
EV (Enterprise Value) |
51.5 млн | -25.5 млн | 289 млн | 67.7 млн | 8.09 млн | 189 млн | 101 млн | 205 млн | 362 млн | 159 млн | 14 млн | 18.8 млн |
EBITDA per Share |
-8.51 | -9.53 | -1.08 | -1.6 | -2.11 | -3.34 | -2.39 | -3.36 | -3.72 | -3.29 | -5.69 | -7.34 |
EV/EBITDA |
1.0 | -4.3 | -0.2 | 0.0 | -2.7 | -2.4 | -4.1 | -9.2 | -8.6 | -0.5 | -0.2 | |
PEG |
-0.0 | 0.0 | -0.13 | -0.03 | 0.04 | -0.11 | 0.16 | 0.43 | 4.65 | 0.24 | 0.05 | -0.03 |
P/B |
0.0 | 0.1 | -2.1 | -4.4 | 1.1 | 2.7 | 1.7 | 2.7 | 8.6 | 5.6 | 3.0 | 2.5 |
P/CF |
-0.1 | -0.1 | -5.6 | -1.1 | -1.4 | -5.2 | -6.0 | -5.1 | -11.5 | -10.6 | -1.0 | -1.6 |
ROE % |
-197.53 | 333.04 | 123.57 | 506.04 | -93.57 | -61.27 | -37.15 | -58.09 | -89.03 | -56.16 | -290.33 | -197.74 |
ROA % |
-23.10 | 281.35 | -265.72 | -119.01 | -82.00 | -55.72 | -33.90 | -52.62 | -75.14 | -49.44 | -177.77 | -92.89 |
ROCE % |
-235.23 | -93.96 | -103.72 | 652.90 | -88.43 | -61.37 | -37.31 | -57.16 | -87.32 | -55.98 | -297.38 | -132.52 |
Current Ratio |
1.6 | 6.4 | 5.9 | 0.8 | 8.1 | 11.5 | 11.9 | 9.3 | 6.0 | 6.9 | 2.5 | 4.1 |
DSO |
158.0 | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
157.9 | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
157.9 | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально Idera Pharmaceuticals
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-2.94 | - | -0.06 | -0.1 | -1.34 | - | -0.11 | -0.15 | 2.66 | - | -0.59 | -0.72 | 0.27 | - | -0.39 | -0.39 | -0.4 | - | -0.43 | -0.59 | -0.81 | - | -0.78 | -1.15 | -0.1 | - | -0.1 | -0.11 | -0.11 | - | -0.1 | -0.11 | -0.12 | - | -0.11 | -0.1 | -0.12 | - | -0.11 | -0.15 | -0.15 | - | -0.17 | -0.15 | -0.25 | - | -0.2 | -0.23 | -0.25 |
EBITDA per Share |
-2.77 | - | -0.17 | -0.1 | -1.34 | - | -0.11 | -0.15 | -0.24 | - | -0.21 | -0.24 | -0.43 | - | -0.39 | -0.4 | -0.41 | - | -0.43 | -0.6 | -0.81 | - | -0.77 | -1.15 | -0.1 | - | -0.11 | -0.11 | -0.11 | - | -0.1 | -0.11 | -0.12 | - | -0.11 | -0.1 | -0.12 | - | -0.1 | -0.09 | -0.14 | - | -0.17 | -0.19 | -0.2 | - | -0.2 | -0.22 | -0.24 |
ROE % |
-151.94 | -56.20 | -74.27 | -77.42 | -72.35 | 235.47 | 258.01 | 298.62 | 345.24 | 39.44 | 139.13 | 216.27 | 289.77 | 298.02 | 279.89 | 162.07 | 36.94 | -74.59 | -88.08 | -83.44 | -78.32 | -47.41 | -59.89 | -58.89 | -52.00 | -37.94 | -51.54 | -52.65 | -54.82 | -43.75 | -65.53 | -73.72 | -77.64 | -61.57 | -76.17 | -68.99 | -60.91 | -37.40 | -698.73 | -1345.46 | -1884.96 | -2187.25 | -2232.90 | -1617.22 | -1118.90 | -154.82 | -45.65 | -52.25 | -56.93 |
ROA % |
-54.01 | -37.03 | -52.25 | -64.49 | -61.34 | 208.83 | 160.35 | 127.11 | 87.00 | -84.82 | -108.26 | -83.23 | -49.63 | -70.09 | -85.98 | -78.43 | -76.85 | -65.36 | -77.63 | -74.01 | -70.19 | -43.12 | -54.51 | -53.64 | -47.42 | -34.63 | -46.95 | -47.87 | -49.74 | -39.63 | -58.01 | -64.08 | -66.45 | -51.97 | -64.82 | -59.28 | -52.87 | -32.92 | -76.06 | -106.35 | -132.52 | -142.68 | -164.12 | -142.43 | -131.06 | -72.73 | -21.45 | -24.54 | -26.74 |
ROCE % |
-115.21 | -86.48 | -104.56 | -77.73 | -72.37 | -61.81 | -53.60 | -27.32 | 1.50 | 31.42 | 133.38 | 227.13 | 321.46 | 306.94 | 288.38 | 167.85 | 39.26 | -75.73 | -89.34 | -84.40 | -78.98 | -47.77 | -60.33 | -59.26 | -52.38 | -38.22 | -51.94 | -53.10 | -55.22 | -43.98 | -65.92 | -74.14 | -78.05 | -61.80 | -76.23 | -68.72 | -60.52 | -37.28 | -710.36 | -1369.02 | -2112.14 | -2205.24 | -2250.40 | -1622.47 | -919.63 | -153.23 | -45.16 | -51.26 | -56.81 |
Current Ratio |
1.4 | 1.6 | 1.9 | 5.1 | 7.0 | 6.4 | 6.3 | 6.6 | 8.4 | 0.3 | 0.3 | 0.3 | 0.3 | 0.8 | 0.8 | 0.8 | 0.8 | 8.1 | 8.1 | 8.1 | 8.1 | 11.0 | 11.0 | 11.0 | 11.0 | 11.5 | 11.5 | 11.5 | 11.5 | 10.6 | 10.6 | 10.6 | 10.6 | 6.4 | 6.4 | 6.4 | 6.4 | 8.3 | 8.3 | 8.3 | 8.3 | 2.6 | 2.6 | 2.6 | 2.6 | 3.4 | 3.4 | 3.4 | 3.4 |
DSO |
118.4 | - | 1828.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
118.4 | - | 1828.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
118.4 | - | 1828.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD